Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
19178-19-9
1256784-26-5
16726-67-3 | 5-Bromo-1-naphthoic acid | AA007W38 | MFCD00092713
1716-83-2 | Ethyl 2-(4-bromo-2-fluorophenoxy)acetate | AA007WK6 | MFCD11174617
151198-82-2 | 1,1,2-TRIS(ETHOXYSILYL)ETHANE | AA007X4D | MFCD07778058
154130-99-1 | Pyridine,1,2,3,6-tetrahydro-5-[3-(4-methylphenyl)-5-isoxazolyl]-1-propyl- | AA007XOS | MFCD00924135
103026-14-8 | 4-Chloro-7-(2-furylmethyl)-5,6-dimethyl-7h-pyrrolo[2,3-d]pyrimidine | AA007Y8C | MFCD09040565
144830-18-2 | (+)-N,O-Di-Desmethyl Tramadol | AA007YXD | MFCD04039514
135308-76-8 | D,L-N,N-Didesmethyl-O-desmethyl Venlafaxine Hydrochloride | AA007ZK0 | MFCD08063792
13403-01-5 | 2-(2,4-Di-tert-pentylphenoxy)butanoic acid | AA00801P | MFCD00045895
1311-10-0 | Strontium hydroxide octahydrate | AA0080HX | MFCD00150395
1186195-01-6 | 2,2,2-Trifluoro-1-p-tolylethanamine hydrochloride | AA0080XC | MFCD11226565
3922-47-2
1203288-83-8
887220-36-2
371217-34-4
Journal: Bioorganic & medicinal chemistry letters20101101